Company: IXHL
Filing Date: 2025-08-08
Form Type: 8-K
Source: 0001213900-25-073321
Chunk: 0

Company: Incannex Healthcare Inc.
Filing Date: 2025-08-08
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

On August 8, 2025, Incannex
Healthcare Inc. Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea.
Further information is included in the press release attached as Exhibit 99.1 hereto, which is incorporated by reference into this Item
8.01.

Item 9.01 Financial Statements and Exhibits.